Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study — China, 2022

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Although a third coronavirus disease 2019 (COVID-19) vaccination (booster) dose is highly recommended for diabetic patients, the vaccination behaviors and related adverse events are unclear among diabetic patients with a COVID-19 booster dose. WHAT IS ADDED BY...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Zhu, Yaxin, He, Zhong, Lan, Xinquan, Song, Moxin, Chen, Xi, Li, Mufan, Yang, Jianzhou, Xu, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902747/
https://www.ncbi.nlm.nih.gov/pubmed/36777467
http://dx.doi.org/10.46234/ccdcw2023.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902747/
https://www.ncbi.nlm.nih.gov/pubmed/36777467
http://dx.doi.org/10.46234/ccdcw2023.002

Ejemplares similares